15 Analysts Assess Axsome Therapeutics: What You Need To Know
15 Analysts Assess Axsome Therapeutics: What You Need To Know
15位分析师对axsome therapeutics进行评估：你需要知道的事项
Throughout the last three months, 15 analysts have evaluated Axsome Therapeutics (NASDAQ:AXSM), offering a diverse set of opinions from bullish to bearish.
在过去的三个月中，15名分析师对axsome therapeutics（纳斯达克:AXSM）进行了评估，提供了从看好到看淡的多样化意见。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格总结了分析师们最近的评级，揭示了过去30天内情绪的变化并将其与前几个月进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $137.8, a high estimate of $190.00, and a low estimate of $106.00. Witnessing a positive shift, the current average has risen by 7.07% from the previous average price target of $128.70.
分析师通过他们对12个月价格目标的评估提供更深入的见解，揭示了一个平均目标价格为137.8美元，最高预估为190美元，最低为106美元。目前的平均价格较上一个平均价格目标128.7美元上涨了7.07%。
Breaking Down Analyst Ratings: A Detailed Examination
分析师评级分析：详细分析
An in-depth analysis of...
对最近分析...
登录免费看全文
登录/注册